top of page

NHP Intraocular Hypertension Study

aldric-hama
Apr 7, 2021
1 min read

Updated: Nov 23, 2021

Neuroprotective effect of brimonidine in a NHP model of ocular hypertension.

Recent Posts

See All

Announcement of an Alliance for Preclinical and Early Clinical Research and Trials in the Development of Radiopharmaceuticals in Japan

Hamamatsu Pharma Research is pleased to announce that our company, in collaboration with Hakuto Co., Ltd. and Samurai Imaging Partners Co., Ltd., has launched the “Radiopharmaceutical Drug Discovery S

HPR Presenting at the SOT, San Diego 2026

HPR Participating in BIO-Europe Spring 2026

Comments

bottom of page